REGENERON PHARMACEUTICALS ($REGN) posted quarterly earnings results on Tuesday, February 4th. The company reported earnings of $12.07 per share, beating estimates of $11.54 by $0.53. The company also reported revenue of $3,789,200,000, missing estimates of $3,844,687,805 by $-55,487,805.
You can see Quiver Quantitative's $REGN stock page to track data on insider trading, hedge fund activity, congressional trading, and more.
REGENERON PHARMACEUTICALS Insider Trading Activity
REGENERON PHARMACEUTICALS insiders have traded $REGN stock on the open market 65 times in the past 6 months. Of those trades, 0 have been purchases and 65 have been sales.
Here’s a breakdown of recent trading of $REGN stock by insiders over the last 6 months:
- CHRISTINE A POON has made 0 purchases and 7 sales selling 10,838 shares for an estimated $12,552,284.
- ANDREW J MURPHY (EVP Research) has made 0 purchases and 18 sales selling 6,363 shares for an estimated $7,337,504.
- CHRISTOPHER R. FENIMORE (SVP Finance & CFO) has made 0 purchases and 10 sales selling 5,680 shares for an estimated $6,846,262.
- NEIL STAHL (EVP Research and Development) has made 0 purchases and 6 sales selling 5,197 shares for an estimated $5,636,346.
- MARION MCCOURT (EVP Commercial) has made 0 purchases and 2 sales selling 2,000 shares for an estimated $2,023,340.
- BONNIE L BASSLER sold 756 shares for an estimated $884,520
- JASON PITOFSKY (VP Controller) sold 487 shares for an estimated $521,090
- ARTHUR F RYAN has made 0 purchases and 20 sales selling 100 shares for an estimated $117,868.
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
REGENERON PHARMACEUTICALS Hedge Fund Activity
We have seen 607 institutional investors add shares of REGENERON PHARMACEUTICALS stock to their portfolio, and 636 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- JPMORGAN CHASE & CO removed 787,815 shares (-9.5%) from their portfolio in Q3 2024, for an estimated $828,182,640
- WELLINGTON MANAGEMENT GROUP LLP removed 621,182 shares (-58.5%) from their portfolio in Q3 2024, for an estimated $653,011,365
- PRICE T ROWE ASSOCIATES INC /MD/ added 342,429 shares (+36.7%) to their portfolio in Q3 2024, for an estimated $359,975,061
- CAPITAL WORLD INVESTORS removed 340,280 shares (-7.3%) from their portfolio in Q3 2024, for an estimated $357,715,947
- VANGUARD GROUP INC added 326,320 shares (+3.6%) to their portfolio in Q3 2024, for an estimated $343,040,636
- FRANKLIN RESOURCES INC added 315,689 shares (+16.4%) to their portfolio in Q3 2024, for an estimated $331,864,904
- FMR LLC removed 286,773 shares (-2.7%) from their portfolio in Q3 2024, for an estimated $301,467,248
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
REGENERON PHARMACEUTICALS Congressional Stock Trading
Members of Congress have traded $REGN stock 6 times in the past 6 months. Of those trades, 0 have been purchases and 6 have been sales.
Here’s a breakdown of recent trading of $REGN stock by members of Congress over the last 6 months:
- REPRESENTATIVE JOSH GOTTHEIMER has traded it 3 times. They made 0 purchases and 3 sales worth up to $45,000 on 11/29, 11/19, 10/23.
- REPRESENTATIVE JONATHAN L. JACKSON has traded it 2 times. They made 0 purchases and 2 sales worth up to $65,000 on 11/13, 11/01.
- REPRESENTATIVE GREG LANDSMAN sold up to $15,000 on 10/15.
To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard.
This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.
